U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07518797) titled 'Advanced Symptom Palliation Through Integrated Relief Engagement' on March 29.
Brief Summary: Beacon is a digital platform that processes objective and subjective aggregated data provided by patients. Objective data is provided by standard wearables, while subjective data is provided by patient-reported outcome measures (PROMs), comprising written and vocal patient reporting.
The ASPIRE.AI study is a prospective study evaluating the feasibility of clinicians' use of aggregated data that was provided by patients and analyzed through "Beacon", and its influence on advanced cancer patients' palliative symptoms management.
Approximat...